WuXi Facility Passes FDA Inspection for Manufacture of API - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

WuXi Facility Passes FDA Inspection for Manufacture of API


WuXiPharmaTech, a pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, announced that a manufacturing facility of WuXi’s wholly owned subsidiary, Shanghai SynTheAll Pharmaceutical (STA), passed an FDA inspection in July for the manufacture of API for a branded commercial drug.

This inspection is the first FDA inspection of STA’s facilities for the manufacture of an API. In 2013, STA’s manufacturing operations passed an inspection by FDA for the manufacture of an advanced intermediate.

Source: WuXiPharmaTech

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here